| | Class 2 Device Recall Elecsys AntiTSHR |  |
| Date Initiated by Firm | November 21, 2025 |
| Date Posted | January 02, 2026 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-1009-2026 |
| Recall Event ID |
98103 |
| 510(K)Number | K193313 |
| Product Classification |
System, test, thyroid autoantibody - Product Code JZO
|
| Product | The Elecsys Anti-TSHR immunoassay is a three-step competitive immunoassay with streptavidin-coated microparticles and electrochemiluminescence detection. Patient serum sample is incubated with pretreatment reagent PT1 and the reconstituted PT2 containing a pre-formed immunocomplex of solubilized porcine TSH receptor (pTSHR) and biotinylated anti-pTSHR mouse monoclonal antibody. |
| Code Information |
08496633190 lot 840183 exp. 02/26
08496633190 lot 874011 exp. 10/26
08496609190 lot 840177 exp. 05/26 |
Recalling Firm/ Manufacturer |
Roche Diagnostics Operations, Inc. 9115 Hague Rd Indianapolis IN 46256-1025
|
| For Additional Information Contact | Roche Support Network Customer Support Center 800-428-2336 |
Manufacturer Reason for Recall | Issues identified: 1) Results vary by Instrument Platform; 2) Calibrator Lot-to-Lot Variability. Issues may lead to delayed or incorrect diagnosis, as well as delay of treatment or incorrect treatment. |
FDA Determined Cause 2 | Process control |
| Action | Firm notified customers on November 21, 2025 via Urgent Medical Device Correction notices. Customers using the cobas e 402/801 and cobas e411 were instructed to immediately discontinue using the impacted lots outlined in the UMDC and switch to the new unaffected lot numbers listed in the communication. |
| Quantity in Commerce | 1300 cassettes |
| Distribution | US Nationwide distribution in the states of AZ, CA, FL, GA, IL, IN, ME, MI, MN, NC, NJ, NM, NY, OH, PA, PR, TN, TX, UT, WA, WV. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
| 510(K) Database | 510(K)s with Product Code = JZO
|
|
|
|